Has nancy pelosi or any other large holders of HUMA sold their huma shares recently and what are the anaylsts buy, sell or hold rating

1. **Recent Selling by Nancy Pelosi**:
- Nancy Pelosi, the former Speaker of the House, disclosed a sale of $100,000 worth of Humacyte (HUMA) shares on April 30, 2024. This sale was made approximately two months after her initial purchase of HUMA shares.
- It is worth noting that Pelosi's sale occurred before the recent decline in the stock's value, and her current holdings are estimated to be around $100,000.
2. **Analyst Ratings and Price Targets**:
- The analyst consensus rating for HUMA is a "Strong Buy" with an average price target of $12.6. This suggests that analysts are optimistic about the stock's future performance.
- It is important to consider that price targets are based on projections and can be influenced by a variety of factors, including market conditions, company performance, and industry trends.
3. **Institutional Position and Changes**:
- As of the latest data, institutional ownership of HUMA stands at 26.21%, with a significant portion of shares held by BlackRock Inc., Vanguard Group Inc, and State Street Corporation.
- There have been no recent significant changes in institutional ownership that would indicate a major shift in sentiment.

In summary, while Nancy Pelosi has sold her HUMA shares, the analyst consensus remains a "Strong Buy" with a higher price target compared to the current trading price, indicating potential upside according to analysts. Institutional ownership is relatively stable, with no recent major selling pressures from institutional investors.